Heart failure management to go cheaper in the country with important drugs losing their patents in January 2023. The drug combination of sacubitril plus valsartan, which is an accepted combination for heart failure, is losing patent.
source https://www.pharmatutor.org/pharma-news/2022/heart-failure-management-to-go-cheaper-in-the-country
No comments:
Post a Comment